These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 18656354)
1. Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer. Sheu BC; Kuo WH; Chen RJ; Huang SC; Chang KJ; Chow SN Breast; 2008 Dec; 17(6):604-10. PubMed ID: 18656354 [TBL] [Abstract][Full Text] [Related]
2. Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer. Chin Y; Janseens J; Vandepitte J; Vandenbrande J; Opdebeek L; Raus J Anticancer Res; 1992; 12(5):1463-6. PubMed ID: 1332579 [TBL] [Abstract][Full Text] [Related]
3. The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer. Matkowski R; Gisterek I; Halon A; Lacko A; Szewczyk K; Staszek U; Pudelko M; Szynglarewicz B; Szelachowska J; Zolnierek A; Kornafel J Anticancer Res; 2009 Jul; 29(7):2445-51. PubMed ID: 19596912 [TBL] [Abstract][Full Text] [Related]
4. [Preliminary study on lymphocyte subsets of sentinel lymph nodes in breast cancer patients]. Wang S; Fan P; Wu ZY Zhonghua Zhong Liu Za Zhi; 2004 Apr; 26(4):220-2. PubMed ID: 15312384 [TBL] [Abstract][Full Text] [Related]
5. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620 [TBL] [Abstract][Full Text] [Related]
6. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. Sheu BC; Hsu SM; Ho HN; Lin RH; Torng PL; Huang SC Cancer; 1999 Oct; 86(8):1537-43. PubMed ID: 10526283 [TBL] [Abstract][Full Text] [Related]
7. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer. Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma. Chen CH; Lee HS; Huang GT; Yang PM; Yu WY; Cheng KC; Lee PH; Jeng YM; Chen DS; Sheu JC Hepatogastroenterology; 2007; 54(77):1529-33. PubMed ID: 17708291 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer. Morton BA; Ramey WG; Paderon H; Miller RE Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262 [TBL] [Abstract][Full Text] [Related]
10. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast. Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203 [TBL] [Abstract][Full Text] [Related]
11. Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer. Reome JB; Hylind JC; Dutton RW; Dobrzanski MJ Clin Immunol; 2004 Apr; 111(1):69-81. PubMed ID: 15093554 [TBL] [Abstract][Full Text] [Related]
12. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Piersma SJ; Jordanova ES; van Poelgeest MI; Kwappenberg KM; van der Hulst JM; Drijfhout JW; Melief CJ; Kenter GG; Fleuren GJ; Offringa R; van der Burg SH Cancer Res; 2007 Jan; 67(1):354-61. PubMed ID: 17210718 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: relation to prognostic variables. Helal TE; Ibrahim EA; Alloub AI Indian J Pathol Microbiol; 2013; 56(2):89-93. PubMed ID: 24056641 [TBL] [Abstract][Full Text] [Related]
14. Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer. Xu L; Xu W; Qiu S; Xiong S Clin Immunol; 2010 Jun; 135(3):466-75. PubMed ID: 20181533 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast. Yakirevich E; Izhak OB; Rennert G; Kovacs ZG; Resnick MB Mod Pathol; 1999 Nov; 12(11):1050-6. PubMed ID: 10574602 [TBL] [Abstract][Full Text] [Related]
16. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma. Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363 [TBL] [Abstract][Full Text] [Related]
17. T-lymphocyte subsets (CD4/CD8 ratio) in breast cancer patients. Sevcíková L; Hunáková L; Chorváth B; Turzová M; Boljesíková E Neoplasma; 1992; 39(4):219-22. PubMed ID: 1436231 [TBL] [Abstract][Full Text] [Related]
18. Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival. Ino K; Yamamoto E; Shibata K; Kajiyama H; Yoshida N; Terauchi M; Nawa A; Nagasaka T; Takikawa O; Kikkawa F Clin Cancer Res; 2008 Apr; 14(8):2310-7. PubMed ID: 18413819 [TBL] [Abstract][Full Text] [Related]
19. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239 [TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]